Skip to content

Discontinued — last reported Q1 '26

EBITDA at other companies

Balchem logo
BalchemBCPC
$68.12M+9.8%
Charles River Laboratories logo
Charles River LaboratoriesCRL
STERIS logo
STERISSTE
Fortive logo
FortiveFTV
Natera, Inc. logo
Natera, Inc.NTRA
Oklo logo
OkloOKLO

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Calculated from Sotera Health’s reported figures.

$7.9Mebit+
$30.8MDepreciation Depletion & Amortization
=$38.68M

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's EBITDA?
Sotera Health (SHC) reported EBITDA of $38.68M in Q1 2026.
How has Sotera Health's EBITDA changed year-over-year?
Sotera Health's EBITDA increased by 359.7% year-over-year, from -$14.9M to $38.68M.
What is the long-term trend for Sotera Health's EBITDA?
Over 4 years (2021 to 2025), Sotera Health's EBITDA has grown at a -25.1% compound annual growth rate (CAGR), from $407.64M to $128.49M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.